Literature DB >> 10928176

Screening for metastatic disease in newly diagnosed breast cancer patients. What is cost-effective?

J Norum1, T Andreassen.   

Abstract

BACKGROUND: Significant health care resources are today spent on diagnosing and treatment of early breast cancer.
MATERIALS AND METHODS: 98 consecutive patients referred to our oncological unit between January 1997 and June 1998 underwent an evaluation programme including thoracic X-ray, liver and bone scan and blood test. When findings suspected for metastatic disease were revealed, further examinations (CT-scan, MRI) were performed.
RESULTS: Whereas the screening programme disclosed four cases (4%) of distant metastasis, several patients had to suffer the psychological distress of false positive results. One in three suspicious thoracic X-rays, two in two liver scans and 18 out of 21 suspected bone scans were concluded false positive in terms of metastatic disease. A screening programme including blood test and thoracic X-ray alone, would have mis-classified one out of 98 patients.
CONCLUSION: This study indicated thoracic X-ray and blood test as being sufficient and 110 Pounds per patient screened could be saved.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928176

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Preoperative FDG PET/CT in breast cancer patients: where are we going?

Authors:  Laura Gilardi; Concetta De Cicco; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11       Impact factor: 9.236

2.  A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancer.

Authors:  C Boutros; C Mazouni; F Lerebours; D Stevens; X Lei; A M Gonzalez-Angulo; S Delaloge
Journal:  Br J Cancer       Date:  2015-03-17       Impact factor: 7.640

3.  Distant metastasis detected by routine staging in breast cancer patients participating in the national German screening programme: consequences for clinical practice.

Authors:  Peter Rusch; Oliver Hoffmann; Anna-L Stickelmann; Stephan Böhmer; Regine Gätje; Karl G Krüger; Stefan Niesert; Andrea Schmidt; Rainer Kimmig
Journal:  Springerplus       Date:  2016-07-07

Review 4.  Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of breast carcinoma: Indications and pitfalls with illustrative case examples.

Authors:  Moheieldin M Abouzied; Ahmed Fathala; Ahmad AlMuhaideb; Mohammed H Al Qahtani
Journal:  World J Nucl Med       Date:  2020-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.